Physician profile
Erin E Katz
NPI 1447296090
$6,060.95
in general payments reported to CMS, 2019-2025
25 companies · $336 in 2025
The $336 reported for 2025 was less than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,334 · 2020: $169 · 2021: $689 · 2022: $810 · 2023: $410 · 2024: $2,314 · 2025: $336.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,907 · Travel and Lodging: $1,152.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,906.74 |
| Travel and Lodging | $1,152.22 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bluewind Medical | $1,437.39 | 2024-2025 | Revi |
| Neotract INC. | $1,314.54 | 2019-2020 | |
| Caldera Medical, INC | $678.00 | 2021-2023 | Desara |
| Teleflex LLC | $560.81 | 2022-2024 | Urolift, Solesta |
| Boston Scientific Corporation | $272.95 | 2020-2025 | Bulkamid, Axonics |
| Astellas Pharma US INC | $266.23 | 2019-2023 | Veozah, Myrbetriq |
| Axonics, INC. | $237.56 | 2021-2024 | Axonics |
| 180 Medical, INC. | $187.85 | 2022-2024 | |
| Pfizer INC. | $148.45 | 2020-2021 | |
| Abbvie INC. | $139.67 | 2022-2024 | |
| Allergan, INC. | $137.97 | 2021 | |
| Femselect INC. | $82.71 | 2024 | Enplace |
| Progenics Pharmaceuticals, INC. | $78.10 | 2025 | |
| Sumitomo Pharma America, INC. | $76.99 | 2023-2025 | Gemtesa |
| Medtronic, INC. | $73.72 | 2025 | Altaviva |
Show all 25 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic USA, INC. | $67.37 | 2019-2020 | |
| Coloplast Corp | $59.94 | 2021 | |
| Janssen Biotech, INC. | $52.74 | 2024 | Erleada, Akeega, Balversa |
| Urovant Sciences INC | $47.31 | 2021-2022 | |
| Laborie Medical Technologies Corp. | $35.51 | 2025 | |
| Telix Pharmaceuticals | $29.55 | 2023 | Illuccix |
| Davol INC. | $21.97 | 2024 | Arista Ah Flexitip |
| Olympus America INC. | $19.86 | 2023 | Itind System |
| Palette Life Sciences, INC. | $18.47 | 2022 | |
| Immunitybio, INC. | $15.29 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Erin Katz listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.